You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Protocol
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 2018545421
Feb 2018383411
Mar 2018585813
Apr 2018474520
May 201858558
Jun 201834349
Jul 201833336
Aug 2018343214
Sep 2018303011
Oct 201810810611
Nov 2018838312
Dec 201867679
Jan 2019616111
Feb 201956568
Mar 2019424226
Apr 2019282922
May 2019303010
Jun 2019232219
Jul 2019424117
Aug 2019363419
Oct 2019505028
Nov 2019403023
Dec 201923218
Jan 2020393514
Feb 2020353316
Mar 2020343417
May 202032329
Jun 2020332921
Jul 202032258
Aug 2020241214
Sep 2020483726
Oct 2020946436
Nov 2020362224
Dec 2020302117
Jan 2021312316
Feb 2021251610
Mar 20211999
Apr 2021201310
May 2021373024
Jun 202119198
Jul 2021222225
Aug 2021222020
Sep 2021161614
Oct 2021272125
Nov 2021522841
Dec 2021302126
Jan 2022403128
Feb 2022201314
Mar 2022453719
Apr 2022725717
May 2022462927
Jun 2022342420
Jul 2022442814
Aug 2022312120
Sep 2022443129
Oct 2022372529
Nov 2022442921
Dec 2022533813
Jan 2023413717
Feb 2023191213
Mar 2023463413
Apr 2023401917
May 2023231619
Jun 2023332412
Jul 2023191517
Aug 2023341923
Sep 2023362710
Oct 2023503313
Nov 2023382116
Dec 2023403016
Jan 2024373716
Feb 2024494719
Mar 2024312826
Apr 2024221811
Total290024091275